# Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection

> **NCT06002503** · PHASE1 · UNKNOWN · sponsor: **PharmaJet, Inc.** · enrollment: 46 (actual)

## Conditions studied

- Vaccine Reaction

## Interventions

- **DRUG:** Venezuelan Equine Encephalitis DNA Vaccine
- **DEVICE:** PharmaJet Stratis Needle-free Injection System
- **DEVICE:** PharmaJet Tropis Needle-free Injection System

## Key facts

- **NCT ID:** NCT06002503
- **Lead sponsor:** PharmaJet, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-16
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06002503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06002503, "Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06002503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*